Michael Mollerus
Lawyers
Filters
Amneal Pharmaceuticals $2.35 billion term loan
We advised Amneal Pharmaceuticals on a new term loan
Venture Global LNG $1 billion senior secured notes offering
We advised Venture Global on its high-yield debt offering
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Coty €500 million senior secured notes offering
The 5.75% senior secured notes are due 2028
JBS USA $2.5 billion senior notes offerings
The investment-grade notes are due 2034 and 2053
Arm $4.87 billion IPO
The deal is the largest U.S. IPO since November 2021
MSCI $697 million acquisition of Burgiss Group
We are advising MSCI on the acquisition
Allegro MicroSystems $420 million acquisition of Crocus Technology
We are advising Allegro MicroSystems on the acquisition
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction
Coty $750 million senior secured notes offering
The 6.625% notes are due 2030